Form 4 holding
Market maker/broker-dealer
ENDRA Life Sciences Inc.
- Security class
- Common Stock
- Shares / value
- 146,012
- Estimated value
- Report date
- 27 Aug 2024
- Price
- Ownership
- By Subsidiary
UBS Group AG - Market maker/broker-dealer at ENDRA Life Sciences Inc.
Issuer-level insider activity
- Role
- Market maker/broker-dealer
- Issuer ticker
- NDRA on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by UBS Group AG since 28 Aug 2025
Reported holdings for UBS Group AG in ENDRA Life Sciences Inc.
Form 4 holding
Market maker/broker-dealer
ENDRA Life Sciences Inc.
- Security class
- Common Stock
- Shares / value
- 146,012
- Estimated value
- Report date
- 27 Aug 2024
- Price
- Ownership
- UBS Securities LLC
Transaction history for UBS Group AG in ENDRA Life Sciences Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.